The production of recombinant biopharmaceuticals with antiviral and antiproliferative properties is one of the major aims of advanced genetic engineering. Interferon alpha 2b belongs to the class of recombinant therapeutics which is equally effective against viral infections and carcinomas. Recombinant human IFN ?2b is widely used FDA approved protein drug with global sale level is expected to reach up to 5.8 billion US dollars by 2010 due to its increased demand as a result of high prevalence of hepatitis infections and carcinomas in developed as well as developing countries including Pakistan. In the current research a process was developed for the production of this recombinant interferon alpha 2b drug by adopting advanced molecular and biochemical strategies. Intragene modifications at specific amino acids were also made to produce antiviral gene sequences with improved antiviral properties. Human interferon alpha 2b gene analysis was also established in blood cancers (AML and ALL) in order to find out mutations of clinical significance in theses cancers.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Dr. Nasir Mahmood is Assistant Professor in University of Health Sciences, Lahore, Pakistan. He has PhD in Biological Sciences (Molecular Biology) from School of Biological Sciences,University of the Punjab, Lahore as well as M.Phil (Molecular Biology) from National Centre of Excellence in Molecular Biology, Lahore.
Dr. Nasir Mahmood is Assistant Professor in University of Health Sciences, Lahore, Pakistan. He has PhD in Biological Sciences (Molecular Biology) from School of Biological Sciences,University of the Punjab, Lahore as well as M.Phil (Molecular Biology) from National Centre of Excellence in Molecular Biology, Lahore.
Dr. Nasir Mahmood is Assistant Professor in University of Health Sciences, Lahore, Pakistan. He has PhD in Biological Sciences (Molecular Biology) from School of Biological Sciences,University of the Punjab, Lahore as well as M.Phil (Molecular Biology) from National Centre of Excellence in Molecular Biology, Lahore.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : moluna, Greven, Allemagne
Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mahmood NasirDr. Nasir Mahmood is Assistant Professor in University of Health Sciences, Lahore, Pakistan. He has PhD in Biological Sciences (Molecular Biology) from School of Biological Sciences,University of the Punjab, Lahore a. N° de réf. du vendeur 4973007
Quantité disponible : Plus de 20 disponibles
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. pp. 176. N° de réf. du vendeur 26128760132
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand pp. 176 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam. N° de réf. du vendeur 131794587
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND pp. 176. N° de réf. du vendeur 18128760142
Quantité disponible : 4 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The production of recombinant biopharmaceuticals with antiviral and antiproliferative properties is one of the major aims of advanced genetic engineering. Interferon alpha 2b belongs to the class of recombinant therapeutics which is equally effective against viral infections and carcinomas. Recombinant human IFN 2b is widely used FDA approved protein drug with global sale level is expected to reach up to 5.8 billion US dollars by 2010 due to its increased demand as a result of high prevalence of hepatitis infections and carcinomas in developed as well as developing countries including Pakistan. In the current research a process was developed for the production of this recombinant interferon alpha 2b drug by adopting advanced molecular and biochemical strategies. Intragene modifications at specific amino acids were also made to produce antiviral gene sequences with improved antiviral properties. Human interferon alpha 2b gene analysis was also established in blood cancers (AML and ALL) in order to find out mutations of clinical significance in theses cancers. N° de réf. du vendeur 9783639273526
Quantité disponible : 2 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82936392735246
Quantité disponible : 1 disponible(s)